MichaelJWagnerMD

Oncology • Boston, MA

Sarcoma

Physician

Join to view full profile

Dr. Wagner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wagner's full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 713-792-6161

Education & Training

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2011 - 2014
Harvard Medical SchoolClass of 2011

Certifications & Licensure

MA State Medical License 2023 - 2026
WA State Medical License 2017 - 2025
AK State Medical License 2018 - 2024
MT State Medical License 2022 - 2024
NY State Medical License 2012 - 2017
TX State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
Active, not recruiting
Phase 3
SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma Start of enrollment: 2021 Nov 11
Recruiting
Phase 3
Roles: Principal Investigator
BTX-A51 in Patients With Liposarcoma Start of enrollment: 2024 Nov 01
Not yet recruiting
Phase 1
Roles: Sponsor-Investigator, Principal Investigator, Contact

Publications & Presentations

PubMed

1 citations
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma.
Kathryn Lurain, Ramya Ramaswami, Irene Ekwede, Vanessa Eulo, Gaurav Goyal
Journal of Clinical Oncology. 2024-10-02
1 citations
Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma.
Ifeanyichukwu U Anidi, Shunsuke Sakai, Kelsie Brooks, Steven P Fling, Michael J Wagner
Open Forum Infectious Diseases. 2024-05-01
14 citations
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia
Lancet. 2024-04-13

Press Mentions

How a Patient Partnership Is Propelling Cancer ResearchSeptember 14th, 2022
High COVID Complication Rates in Sarcoma PatientsNovember 12th, 2021
ASCO Annual Meeting to Highlight Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA)May 21st, 2020